| Post date: 2019/12/8 |
About the Journal
Plant Biotechnology Persa (PBP) is an open-access peer-reviewed biannual international journal published by the Ilam University of Medical Sciences, Iran, devoted to the fields of medicinal plants, biotechnology, and toxicology. The journal focuses on the research, teaching, and application of medicinal plants for the treatment of diseases and all fields of medical and herbal biotechnology and toxicology. The journal is the intersection between medicinal plants, biotechnology, and toxicology. This international journal aims to reach all relevant national and international medical institutions and persons in the electronic version free of charge. It is an interdisciplinary journal devoted to the publication of original articles, review articles, etc., considering research ethics and academic rules and regulations.
Aims and Scope
Plant Biotechnology Persa (PBP) is the intersection between medicinal plants and biotechnology. This international journal publishes manuscripts in the fields of medicinal plants, biotechnology, and toxicology. This journal aims to reach all relevant national and international medical institutions and persons in electronic versions free of charge. Plant Biotechnology Persa (PBP) has pursued this aim by publishing editorials, original research articles, reviews, mini-reviews, commentaries, letters to the editor, hypotheses, case reports, meta-analyses, epidemiology and prevention, news, and views. In this journal, particular emphasis is given to research, both experimental and clinical, aimed at the protection/prevention of diseases. A further aim of this journal is to emphasize and strengthen the link between herbalists and pharmacologists, medical and herbal biotechnologies, and toxicologists. In addition, Plants Biotechnology Persa welcomes basic and clinical biomedical as well as pharmaceutical scientific research applied to clinical pharmacology with the attitude of medicinal plants. Contributions in any of these formats are invited for editorial consideration following peer review by at least two experts in the field.
Plant Biotechnology Persa is an online peer-reviewed international journal to promote all fields of medicinal plants like herbal drugs, bioactive compounds, green chemistry, phytomedicine, phytochemistry, ethno-botany, ethno-pharmacology, ethno-medicine, phyto-pharmacology, pharmacognosy, clinical, pharmacological, pharmacokinetic, and toxicological studies of specified herbal medicinal products, herbal preparations, and purified compounds as well as all aspects of Biotechnology, etc. The journal also publishes papers in the following fields: plant biotechnology, which includes plant genetics, plant biochemistry, plant physiology, and medicinal chemistry; human biotechnology, which covers the fields of nanomaterials, biomedical, toxicology, microbial, genetic, biomaterials, vaccine, and environmental aspects, and the diagnostic field with biotechnological methods; and toxicology, publishing papers related to the toxicological aspects of pharmaceutical substances, biochemical agents and heavy metals.
Plant Biotechnology Persa (PBP) is an open-access peer-reviewed biannual international journal published by the Ilam University of Medical Sciences, Iran, devoted to the fields of medicinal plants, biotechnology, and toxicology. The journal focuses on the research, teaching, and application of medicinal plants for the treatment of diseases and all fields of medical and herbal biotechnology and toxicology. The journal is the intersection between medicinal plants, biotechnology, and toxicology. This international journal aims to reach all relevant national and international medical institutions and persons in the electronic version free of charge. It is an interdisciplinary journal devoted to the publication of original articles, review articles, etc., considering research ethics and academic rules and regulations.
Aims and Scope
Plant Biotechnology Persa (PBP) is the intersection between medicinal plants and biotechnology. This international journal publishes manuscripts in the fields of medicinal plants, biotechnology, and toxicology. This journal aims to reach all relevant national and international medical institutions and persons in electronic versions free of charge. Plant Biotechnology Persa (PBP) has pursued this aim by publishing editorials, original research articles, reviews, mini-reviews, commentaries, letters to the editor, hypotheses, case reports, meta-analyses, epidemiology and prevention, news, and views. In this journal, particular emphasis is given to research, both experimental and clinical, aimed at the protection/prevention of diseases. A further aim of this journal is to emphasize and strengthen the link between herbalists and pharmacologists, medical and herbal biotechnologies, and toxicologists. In addition, Plants Biotechnology Persa welcomes basic and clinical biomedical as well as pharmaceutical scientific research applied to clinical pharmacology with the attitude of medicinal plants. Contributions in any of these formats are invited for editorial consideration following peer review by at least two experts in the field.
Plant Biotechnology Persa is an online peer-reviewed international journal to promote all fields of medicinal plants like herbal drugs, bioactive compounds, green chemistry, phytomedicine, phytochemistry, ethno-botany, ethno-pharmacology, ethno-medicine, phyto-pharmacology, pharmacognosy, clinical, pharmacological, pharmacokinetic, and toxicological studies of specified herbal medicinal products, herbal preparations, and purified compounds as well as all aspects of Biotechnology, etc. The journal also publishes papers in the following fields: plant biotechnology, which includes plant genetics, plant biochemistry, plant physiology, and medicinal chemistry; human biotechnology, which covers the fields of nanomaterials, biomedical, toxicology, microbial, genetic, biomaterials, vaccine, and environmental aspects, and the diagnostic field with biotechnological methods; and toxicology, publishing papers related to the toxicological aspects of pharmaceutical substances, biochemical agents and heavy metals.
| Bibliographic Information | |
| Title | Plant Biotechnology Persa |
| Journal Abbreviated Title | Plant Biotechnol. Persa |
| Journal Title Acronym | PBP |
| ISSN | Online ISSN: 2676-7414 |
| Subject Area and Category | Subject Area and Category based on Scopus: Agricultural and Biological Sciences -- Plant Science Biochemistry, Genetics and Molecular Biology -- Biotechnology Medicine -- Complementary and Alternative Medicine Pharmacology, Toxicology and Pharmaceutics -- Drug Discovery Interdisciplinary pharmacology, medical biotechnology and clinical medicine |
| Coverage | - Herbal drugs - Bioactive compounds - Green Chemistry - Phytomedicine - Phytochemistry - Ethno-botany - Ethno-pharmacology - Ethno-medicine - Phyto-pharmacology - Pharmacognosy - Clinical, Pharmacological - Pharmacokinetic - Toxicological studies of specified Herbal medicinal products - Herbal preparations - Plant physiology - Toxicology (Toxicological aspects of pharmaceutical substances, biochemical agents and heavy metals) - Plant biotechnology (Plant genetics, plant biochemistry, plant physiology, and medicinal chemistry) - Human biotechnology (Nanomaterials, biomedical, toxicology, microbial, genetic, biomaterials, vaccine, and environment aspects and diagnostic field with biotechnological methods) - Interdisciplinary pharmacology, medical biotechnology and clinical medicine |
| Language | English |
| Start Year | 2019 - Vol. 1, No. 1 - |
| Frequency | Semi-annual |
| Editor-in-Chief | Naser Abbasi, Associated Professor. |
| Associate Editor | Mahmoud Bahmani, Assistant Professor. |
| Place of Publication | Iran, Ilam |
| Publisher | Ilam University of Medical Sciences |
| Status | Active |
| Peer Review Policy | Double Blind Peer Review. |
| Primary Review | 10 days, approximately. |
| Average refereeing time | 14 weeks |
| Acceptance and Publication Time | 16 Weeks |
| Manuscript acceptance rate | 30% |
| OCLC No. | 1145219312 |
| URL | https://pbp.medilam.ac.ir |
| Type of Papers | - Research - Review - Case Report - Letter to Editor |
| Type of Access | Open Access (OA) |
| OA Policies | SHERPA/RoMEO |
| Type of License | CC-BY-NC: Creative Commons - Attribution 4.0 International. |
| Open Access Statement | Plant Biotechnology Persa journal provides immediate open access to the content on the principle that making research freely available to people are increasingly supporting the universal exchange of knowledge in the field of medicinal plants, biotechnology, and toxicology. All content of the journal is published with open access under the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). This license allows users to copy and redistribute the article under the following conditions: - Share — copy and redistribute the material in any medium or format. - Adapt — remix, transform, and build upon the material. Benefits of open access for authors include: - Increased visibility and readership. - Authors retain copyright to their work. - Free access for all users worldwide. - No spatial constraints. No publication charges are required from the author(s). |
| The Policy of Screening for Plagiarism | All manuscripts must be free from plagiarism contents. Manuscripts submitted to the journal of Public Management Researches (PMR) will be screened for plagiarism using similarity check and plagiarism detection tools, duplicated publication, data fabrication, and falsification. Plant Biotechnology Persa is committed to publishing original studies and timely reviews that have neither been published nor are under review elsewhere. Plant Biotechnology Persa is powered by iThenticate™ and all the submitted manuscripts (MSs) are subjected to the CrossCheck. Taken all, all plagiarized materials will incur the “Plagiarism Sanctions”. Submitted MSs, which are found to be published or under review elsewhere, will be sustained and experience the “Duplicated Publication Sanctions”. Submitted MSs, which are found to include either fabricated or falsified data including the manipulation of images, will confront the “Data Fabrication/Falsification Sanctions”. Whenever it is determined that the manuscript has not complied with the plagiarism rules, the article is rejected (before accepting), and if it has been published (after accepting), it will be removed from the published list and placed in the withdrawn list (returned articles because of Failure to observe plagiarism law). The journal will immediately reject papers leading to plagiarism or self-plagiarism. Whenever it is determined that the manuscript has not complied with the plagiarism rules, it will be REJECTED (before acceptance for publication), and if it was published, it will be RETRACTED for plagiarism issues. The journal of Plant Biotechnology Persa (PBP) aims to ensure that all authors are careful and comply with international standards for academic integrity, particularly on the issue of plagiarism. Plagiarism occurs when an author takes ideas, information, phrases, or words from another source without proper credit to the source. Even when it occurs unintentionally, plagiarism is still a serious ethical violation and unacceptable in scientific academic publications. When the author takes an idea from another author, a citation is required even if the author then develops the idea further. This might be an idea about how to interpret the data, either what methodology to use or what conclusion to draw. It might be an idea about broad developments in a field or general information. Regardless of the idea, authors should cite their information sources. In cases where the author develops the idea further, it is still necessary to cite the original source of the idea, and then in a subsequent sentence, the author can explain his or her more developed idea. When the author takes words from another author, a citation and quotation marks are required. Whenever four or more consecutive words are identical to a source that the author has read, the author must use quotation marks to denote the use of another author's original words; just a citation is no longer enough. |
| Retraction Policy | An article may be retracted when its findings are no longer considered trustworthy due to scientific misconduct or error, it plagiarizes previously published work, or it is found to violate ethical guidelines. An article may be retracted when the integrity of the published work is substantially undermined owing to errors in the conduct, analysis, and/or reporting of the research. Violation of publication or research ethics may also result in a study’s retraction. The original paper will be marked as RETRACTED but a PDF version remains available to readers, and the RETRACTION statement is bi-directionally linked to the original published paper. Retraction statements will typically include a statement of assent or dissent from the authors. |
| Type of Publication (Processing Charges and Publication Charges) | Authors do not need to pay an article-processing charge. Also, Plant Biotechnology Persa (PBP) has no article submission and publishing charges |
| Copyright owner / Copyright holder | Authors retain unrestricted copyrights and publishing rights. The author has complete control over the work (e.g., retains the right to reuse, distribute, republish, etc.). |
| Revenue Sources | Ilam University of Medical Sciences |
| Description | Plant Biotechnology Persa (PBP) is an open-access peer-reviewed biannual international journal published by the Ilam University of Medical Sciences, Iran, devoted to the fields of medicinal plants, biotechnology, and toxicology. The journal focuses on the research, teaching, and application of medicinal plants for the treatment of diseases and all fields of biotechnology and toxicology. Plant Biotechnology Persa (PBP) is the intersection between medicinal plants, biotechnology, and toxicology. This international journal aims to reach all relevant national and international medical institutions and persons in the electronic version free of charge. It is an interdisciplinary journal devoted to the publication of original articles, review articles, etc., considering the research ethics and academic rules and regulations. |
| Copyright Notice | Authors who publish in this journal agree to the following terms: - Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0), which allows users to Share — copy and redistribute the material in any medium or format; and to Adapt — remix, transform, and build upon the material. - Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access). |
| Authorship | The consent of all authors, as well as related authorities/institutions, has been received prior to the submission of the manuscript. The order of the authors (as to be reflected in the published article) has been established. The adding or deleting of authors once the manuscript has been accepted for publication would have to be accompanied by a signed statement of consent from all authors. All authors have contributed significantly to the research. Authors are obligated to participate in the peer review process, providing retractions/corrections/amendments when necessary. All conflicts of interest/financial support have been declared. Any changes or corrections to a published work require the consent of all authors. |
| Publication Ethics |
Plant Biotechnology Persa follows the policies and guidelines of the International Committee of Medical Journal Editors (ICMJE), the World Association of Medical Editors (WAME), and the Committee on Publication Ethics (COPE). |
| Digital Archiving Policy | The journal of Plant Biotechnology Persa (PBP) works with some organizations such as the Islamic World Science Citation Database (ISC), Ilam University of Medical Sciences our own digital archive. This makes possible the permanent availability and preservation of scholarly research and ensures accessibility by converting and upgrading digital file formats to comply with new technology standards. |
| Data Citation | When citing or making claims based on data, authors must refer to the data at the relevant place in the manuscript text and, in addition, provide a formal citation in the reference list. The journal of Public Management Researches (PMR) follows the format proposed by the Joint Declaration of Data Citation Principles: Authors; Title; Journal name; Year; Volume; Issue; pages; DOI. For example Authors (E. Ibrahim M, Halfawi Shargi A, F. Magbool F). Title (Antihepatotoxic Effect of Eruca sativa Mill. Extracts on Alcohol Induced Liver Injury in Rats). Journal name (Plant Biotechnology Persa) Year (2022); Volume(4); Issue ((2)); Pages (1-11). |
| Informed Consent | All participants in human subjects' articles have a right to privacy that should not be violated without informed consent. Identifying information, including names, initials, etc., should not be published in written descriptions, photographs, or pedigrees unless the information is essential for scientific purposes and the participants (or parent or guardian) give written informed consent for publication. Informed consent in this situation requires that an identifiable participant be shown the manuscript, providing consent before publication. Authors should disclose to these patients whether any potential identifiable material might be available via the Internet as well as in print after publication. Participants' consent should be written and archived either with the journal of Plant Biotechnology Persa (PBP), the authors, or both, as dictated by local regulations or laws. |
| Declaration of generative AI in scientific writing | Where authors use generative artificial intelligence (AI) and AI-assisted technologies in the writing process, they should only employ these technologies to improve readability and language. The application of AI technology must be accompanied by human oversight and control. Authors should carefully review and edit the results because AI can generate authoritative-sounding output that can be incorrect, incomplete, or biased. AI and AI-assisted technologies should not be listed as authors or co-authors, nor should they be cited as an author. Authorship implies tasks and responsibilities that are uniquely attributed to and performed by humans. Authors should disclose their use of AI and AI-assisted technologies in the writing process by following the instructions provided. A statement acknowledging this use will appear in the published article. It is essential to recognize that authors remain ultimately responsible and accountable for the content of their article. Disclosure instructions: Authors should disclose in their manuscript the use of generative AI and AI-assisted technologies in the writing process by adding a statement at the end of their manuscript in the core manuscript file, before the References list. The statement should be placed in a new section entitled ‘Declaration of Generative AI and AI-assisted technologies in the writing process’. Statement: During the preparation of this work the author(s) used [NAME TOOL / SERVICE] in order to [REASON]. After using this tool/service, the author(s) reviewed and edited the content as needed and take(s) full responsibility for the content of the publication. This declaration does not apply to the use of basic tools for checking grammar, spelling, references, etc. If there is nothing to disclose, there is no need to add a statement. |
| Privacy Statement |
The names and e-mail addresses entered in this journal website will be used exclusively for the stated purposes of this journal and will not be made available for any other purposes or to any other parties. |
| Human and animal rights | When preparing or writing a manuscript, authors must comply with and report experiments on human beings according to the rules and ethical standards of the Committee responsible for human experiments. The authors should explain their approach and show whether the organizational review body has explicitly endorsed and followed the suspicious aspects of the study. Reports of experimental experiments on animals should also indicate whether the organizational and national guidelines for the care and use of laboratory animals have been complied with. |
PBP publication benefits:
- Free access to the full text of all articles published in the PBP.
- Easy and quick online submission system.
- Free of charge and rapid publication.
- A DOI (digital object identifier) for published articles.
- Easy and quick online submission.
How long will the refereeing process and the acceptance of the article last?
Based on the submission instructions, the article will be read for a maximum of one week if the authors' instructions are carefully followed. In case of initial acceptance in the first stage, the article will be evaluated by the editor and assistant editor from a scientific point of view and based on the content. This stage usually takes two months. According to the conditional acceptance in the second stage, the articles will be sent to the referees. Acceptance may take up to six months, depending on required revisions, reviewers' comments, and quick and accurate changes by authors.
How to know the status of the submitted article?
Only the author of the article can see the latest status of the article. Any changes in the article can be seen and tracked on the journal's website and the author's profile. Also, when the status of the article changes, the author is notified through the website and email, and other authors can receive news about the article from the author.
How to complaint?
Complaint Process:
The authors have the right to complain and ask explanation if they perceive any misconduct in any applicable policies and ethical guidelines. The authors can raise their complaints by submitting a letter to: plant biotechnologypersa
gmail.com and pbpmedilam.ac.ir.We follow the COPE guidelines on responding to whistleblowers, which includes protecting the anonymity. All the complaints regarding delinquencies in the work processes are investigated according to the prevailing publication ethics practices. An author or any other scholar may submit their complaints about any issues related to:
- Plagiarism;
- Copyright violation;
- Deceiving in research results or wrong research results;
- Violations of the research ethics and integrity;
- Unrevealed conflicts of interest;
- Bias in the review process;
- Manuscript processing time is unusually late;
- The peer-review comments are unsatisfactory; and
- Authorship issues.
- Copyright violation;
- Deceiving in research results or wrong research results;
- Violations of the research ethics and integrity;
- Unrevealed conflicts of interest;
- Bias in the review process;
- Manuscript processing time is unusually late;
- The peer-review comments are unsatisfactory; and
- Authorship issues.
Policy for Dealing with Complaints:
Once a complaint is received, at first, an acknowledgment is sent to the complainant with the assurance that appropriate action will be taken on the complaint within three working days excluding the complaint receiving date. The investigation process is initiated by the journal handling team according to the directions of the Editor-In-Chief. After the investigation is over, a meeting is held with a complete report on the complaint. The decision is taken in and the same is forwarded to the concerned scholar through his/her submitted email ID. We consider complaints as an opportunity to enhance our existing Manuscript Processing System. All the received complaints are dealt with in a polite and timely manner with certainty.
Structure and Preparation of Manuscripts
Required files:
Structure of Articles:
Manuscripts should be presented in the following formats:
-
Title page
-
Author(s)
-
Affiliation (s)
-
Abstract (Introduction, Objective, Materials and Methods, Results and Conclusion)
-
keywords
-
Introduction
-
Objective
-
Materials and Methods
-
Results
-
Discussion
-
Acknowledgment
-
Conflicts of interest
-
Ethical considerations
-
Funding
-
References
General Considerations
- The manuscript should be written in good English (American or British usage is accepted, but not a mixture of these).
- All manuscripts must be typed double-spaced, two columns, in size 12 font, and adequate margins should be left.
- No manuscripts submitted to the journal can exceed 6000 words.
- Submitted manuscripts to the Plants Biotechnology Persa should not be under consideration for publication elsewhere.
- All manuscripts must be typed double-spaced, two columns, in size 12 font, and adequate margins should be left.
- No manuscripts submitted to the journal can exceed 6000 words.
- Submitted manuscripts to the Plants Biotechnology Persa should not be under consideration for publication elsewhere.
View: 3385 Time(s) |
Print: 504 Time(s) |
Email: 0 Time(s) |
0 Comment(s)